Literature DB >> 10050753

Stimulation of ultraviolet-induced apoptosis of human fibroblast UVr-1 cells by tyrosine kinase inhibitors.

T Hiwasa1, Y Arase, Z Chen, K Kita, K Umezawa, H Ito, N Suzuki.   

Abstract

Damnacanthal is an anthraquinone compound isolated from the root of Morinda citrifolia and was reported to have a potent inhibitory activity towards tyrosine kinases such as Lck, Src, Lyn and EGF receptor. In the present study, we have examined the effects of damnacanthal on ultraviolet ray-induced apoptosis in ultraviolet-resistant human UVr-1 cells. When the cells were treated with damnacanthal prior to ultraviolet irradiation, DNA fragmentation was more pronounced as compared to the case of ultraviolet irradiation alone. The other tyrosine kinase inhibitors, herbimycin A and genistein, also caused similar effects on ultraviolet-induced apoptosis but to a lesser extent. Serine/threonine kinase inhibitors, K252a, staurosporine and GF109203X, rather suppressed the ultraviolet-induced DNA cleavage. Immunoblot analysis showed that pretreatment with damnacanthal followed by ultraviolet irradiation increased the levels of phosphorylated extracellular signal-regulated kinases and stress-activated protein kinases. However, the other tyrosine kinase inhibitors did not increase the phosphorylation of extracellular signal-regulated kinases but stimulated phosphorylation of stress-activated protein kinases. Consequently, the ultraviolet-induced concurrent increase in both phosphorylated extracellular signal-regulated kinases and stress-activated protein kinases after pretreatment with damnacanthal might be characteristically related to the stimulatory effect of damnacanthal on ultraviolet-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10050753     DOI: 10.1016/s0014-5793(99)00057-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Using quality of life measures in a Phase I clinical trial of noni in patients with advanced cancer to select a Phase II dose.

Authors:  Brian F Issell; Carolyn C Gotay; Ian Pagano; Adrian A Franke
Journal:  J Diet Suppl       Date:  2009

2.  Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells.

Authors:  Thararat Nualsanit; Pleumchitt Rojanapanthu; Wandee Gritsanapan; Seong-Ho Lee; Darunee Lawson; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2011-08-17       Impact factor: 6.048

3.  Case Study of Noni Extract in Men with Very Low-Risk or Low-Risk Prostate Cancer.

Authors:  Yosuke Hirasawa; Ian Pagano; Jeffrey Huang; Yuka Sasaki; Kaoru Murakami; Charles J Rosser; Hideki Furuya
Journal:  Hawaii J Health Soc Welf       Date:  2021-10

4.  Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells.

Authors:  Muhammad Yusran Abdul Aziz; Abdul Rahman Omar; Tamilselvan Subramani; Swee Keong Yeap; Wan Yong Ho; Nor Hadiani Ismail; Syahida Ahmad; Noorjahan Banu Alitheen
Journal:  Oncol Lett       Date:  2014-02-20       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.